A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study
Saved in:
| Published in | Gynecologic oncology Vol. 133; p. 3 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.06.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Author | Michael, H O'Malley, D.M Bakkum-Gamez, J.N Mannel, R.S Miller, A Behbakht, K |
|---|---|
| Author_xml | – sequence: 2 fullname: Miller, A – sequence: 3 fullname: O'Malley, D.M – sequence: 4 fullname: Mannel, R.S – sequence: 5 fullname: Behbakht, K – sequence: 6 fullname: Bakkum-Gamez, J.N – sequence: 7 fullname: Michael, H |
| BookMark | eNqFkc9u1DAQhyNUJLaFJ-DiIwgljO38MxJIqwqWlRb1UDhbjjNZvCT2ynaqpm_G2-G0nLhwmjn8Ps_4m8vswjqLWfaaQkGB1u9PxXJcrCsY0LIAXgBjz7INBVHldVuJi2wDICBvWdW-yC5DOAEAB8o22e8t8cr2bjIP2JPzTxWQ7Pd7Er1RI3EDOeKkTVSdsUjekd5pjOoex9R3eKe0eZgn1RHnyXlUGjtHVCCD8SHm44pEjypOaCMZUmZKcIgqGk3miH4NjGjctLigvHaTIm_mw7fbtx_IluwWi9qN7pjCN_axW8jOu_lMQpz75WX2fFBjwFd_61X248vn79df88PNbn-9PeSaAWe5pnUjhhob0TQd46obONf9IHolaNlRVLQVJa06rrHnAlQJTAwayrpv2gqE5lcZf3pXexeCx0GevZmUXyQFudqXJ_loX672JXCZ7Cfq4xOFabU7g14GbdCmIcajjrJ35j_8p394nXwarcZfuGA4udnb9GtJZWAS5O163_W8tARIhfM_hcOo-g |
| CitedBy_id | crossref_primary_10_1016_j_ejogrb_2021_11_423 crossref_primary_10_1007_s11912_014_0405_1 crossref_primary_10_1155_2015_704124 |
| ContentType | Journal Article |
| Copyright | 2014 |
| Copyright_xml | – notice: 2014 |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.ygyno.2014.03.022 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1095-6859 |
| EndPage | 3 |
| ExternalDocumentID | 10_1016_j_ygyno_2014_03_022 S0090825814002583 1_s2_0_S0090825814002583 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LG5 M29 M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX CITATION |
| ID | FETCH-LOGICAL-c2032-c1679f6e7977b23abf33cdf9da914b1ea189415b3ced390a4029fc046d78509c3 |
| IEDL.DBID | .~1 |
| ISSN | 0090-8258 |
| IngestDate | Thu Sep 26 17:59:34 EDT 2024 Fri Feb 23 02:28:45 EST 2024 Tue Oct 15 22:55:38 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2032-c1679f6e7977b23abf33cdf9da914b1ea189415b3ced390a4029fc046d78509c3 |
| PageCount | 1 |
| ParticipantIDs | crossref_primary_10_1016_j_ygyno_2014_03_022 elsevier_sciencedirect_doi_10_1016_j_ygyno_2014_03_022 elsevier_clinicalkeyesjournals_1_s2_0_S0090825814002583 |
| PublicationCentury | 2000 |
| PublicationDate | June 2014 |
| PublicationDateYYYYMMDD | 2014-06-01 |
| PublicationDate_xml | – month: 06 year: 2014 text: June 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | Gynecologic oncology |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| SSID | ssj0003012 |
| Score | 2.1351414 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | 3 |
| SubjectTerms | Hematology, Oncology and Palliative Medicine Obstetrics and Gynecology |
| Title | A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0090825814002583 https://dx.doi.org/10.1016/j.ygyno.2014.03.022 |
| Volume | 133 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT5xAFJ8YmzS9GGvbuNqad_DQRqkLwwLT28aou13XJrZGb5P5wtIIbGTXiIf-X_53vhnAtmnTgycGwgDhvXm_34P3Qch2ZELt0wHz0Gvro4OSaC-RCfVYIEwSaxkp90F_ehKNzsLPF4OLJbLf5cLYsMrW9jc23Vnr9she-zb3Zllmc3xtu-6BLdmEwJ3Yip8hwh_q9Mefv8I8UIGbiuEuZXqQdJWHXIxXfVkXNgPQD12l0yD4Nzr9hjiHq2SlpYowbJ7mJVkyxRp5Pm1_hr8i90NAoNFlnt0ZDbPviEcwHo_BNeKAMoVLkyt0_dH3NbADGpFqLm7NFY6luREqu1vkQkJ5DS4wS5YgKkgzpIOe5Z7wGIMOSGwhx8k2-yhTYLtA2BOuTFbmdVnhWilzAe8Xx9OvHz7BEI7qwqjGqsKXwo1qcF-5wJWzfU3ODg--7Y-8thODp2yHdU_ZnzVpZGJkizKgQqaUKp0yLZgfSt8IP2HIBCRFqVHWF-iUslSh663jBEWi6BuyXJSFWSegY40eZSClYLa0vWLIIQKtQ6aYxsvpHtntJMBnTcEN3kWi_eBOYNwKjPcpR4H1SNxJiXe5pGj9TNUuxYr7vAp4n_-lLj0SPc78Q-M4gsn_brnx1Imb5IXdawLN3pLl-fXCvENKM5dbTme3yLPheDI6sdvJ6fnkAc85-go |
| link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5tAEF6lidT2EvWpuOljDjk0alAMi4HtzYqamsR2Dk2k3Fb7wqUKYAW7Kvln_XedXcBq1aiH3hCwgJjZmW92Z74h5CAyofbpiHkYtQ0xQEm0l8iEeiwQJom1jJRb0J_No8lVeHY9ut4iJ30tjE2r7Gx_a9Odte7OHHd_83iZ57bG17brHlnKJnTcCX1AdhANMJydO-P0fDLfGGTU4ZY03FVNj5KefMileTWLprRFgH7oyE6D4H4H9ZvTOX1Cdju0COP2g56SLVM-Iw9n3X74c_JzDOhrdFXkd0bD8iu6JEjTFFwvDqgyWJhCYfSP4a-BD6DRWa3ED3ODx9J8Fyq_WxdCQnULLjdLViBqyHJEhJ6Fn7BJQwfEtlDgYFuAlCuwjSDsDTcmr4qmqnG6VIWA9-vp7MvhRxjD56Y0qjWscFG6owbcQhc4RtsX5Or00-XJxOuaMXjKNln3lN2vySITI2CUARUyo1TpjGnB_FD6RvgJQzAgKQqOsqHAuJRlCqNvHScIShR9SbbLqjR7BHSsMagMpBTMstsrhjAi0Dpkiml8nB6Qo14CfNlybvA-Ge0bdwLjVmB8SDkKbEDiXkq8LydFA2jqbjbW3Od1wIf8L40ZkGgz8g-l4-hP_vXKV_878B15NLmcTfk0nZ_vk8f2Spt39ppsr27X5g0inJV822nwL4mC-xs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+randomized+phase+III+trial+of+gemcitabine+%2B+docetaxel+%2B+bevacizumab+or+placebo+as+first-line+treatment+for+metastatic+uterine+leiomyosarcoma+%28uLMS%29%3A+A+Gynecologic+Oncology+Group+study&rft.jtitle=Gynecologic+oncology&rft.au=Hensley%2C+M.L.&rft.au=Miller%2C+A.&rft.au=O%27Malley%2C+D.M.&rft.au=Mannel%2C+R.S.&rft.date=2014-06-01&rft.pub=Elsevier+Inc&rft.issn=0090-8258&rft.eissn=1095-6859&rft.volume=133&rft.spage=3&rft.epage=3&rft_id=info:doi/10.1016%2Fj.ygyno.2014.03.022&rft.externalDocID=S0090825814002583 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00908258%2FS0090825814X00089%2Fcov150h.gif |